Galmed Pharmaceuticals
Allen Baharaff began their work experience in 2000 as the CEO of Galmed Pharmaceuticals Ltd. Allen also served as the Managing Director at T+M during the same year.
Allen Baharaff completed their Bachelor of Science (BSc) in Economics at The London School of Economics and Political Science (LSE). Following this, they pursued a Master of Arts (MA) in Law at the University of Cambridge.
This person is not in any offices
Galmed Pharmaceuticals
Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of Aramchol, a novel, once-daily, oral therapy for treating liver diseases utilizing its proprietary first-in-class family of syntheti...